State-of-the-Art Lecture: Transplanting the Critically Ill Patient
For ILTS members only, please join now or renew your membership.
This webinar gives an overview of the commonly challenging scenario of transplanting the critically ill patient. Our expert guests will address the modern approaches and tools to optimizing pre- and peri-operative management of these patients.
- Identify when and how the critically ill patients can undergo liver transplantation
- Provide an overview of the modern role of the Liver Transplant Anesthesiologist in patient care from the time of selection to the time of transplantation
- Understand the current state of liver support systems in managing critically ill patients with liver disease
- Introduction of the State-of-the-Art-Lecture (Manhal Izzy)
- Liver support systems: Where are we now? (Jean-Charles Duclos-Vallée)
- Too sick for transplant? The Anesthesiologist's role in candidates selection and transplantation (Annabel Blasi)
- Closing Remarks
|Dr. Duclos-Vallée is a professor of Hepatology at the Centre Hépato-Biliaire, Paul-Brousse Hospital, Villejuif, France. He is the president of the French Institute of Biofabrication: https://ifbf-institute.org and the coordinator of the University Hospital Federation “Hepatinov” which promotes innovative projects in Hepatology and more particularly in liver regenerative medicine: https://ifbf-institute.org. His areas of expertise are end stage liver disease, liver transplantation, rare liver disorders, and bioengineering|
|Dr. Blasi is an Anesthesiology consultant in the liver transplant team at the Hospital Clinic in Barcelona. She is also a researcher at the University of California San Francisco (UCSF), and University Medical Centre Groninga (UMCG) laboratory. Her areas of interest are coagulation in liver disease and perioperative management of liver transplant candidates.|
|Dr. Izzy is an Assistant Professor of Medicine and a Transplant Hepatology consultant at Vanderbilt University Medical Centre. He serves as the chair for the education and scholarship committee of ILTS and the co-chair/topic coordinator for the Cardiovascular Special Interest Group of ILTS. His main research interest is in clinical outcomes that relate to Cirrhotic Cardiomyopathy and cardiovascular disease in liver transplant candidates and recipients. He is one of the founding members for the Cirrhotic Cardiomyopathy Consortium that published the new diagnostic criteria for Cirrhotic Cardiomyopathy in 2020.|